Remaining innovative without sacrificing stability: an analysis of strategies in the Japanese pharmaceutical industry that enable firms to overcome inertia resulting from successful market penetration of new product development

M. Takayama، نويسنده , , C. Watanabe، نويسنده , , C. Griffy-Brown، نويسنده ,

روزنامه با شماره پیاپی سال 2002

13

747

759

Institutional elasticity , co-evolution , innovation , Trade-off , new product development , Flexibility

Technovation

2002

Technovation

194687